Treatment With N-Acetylcysteine in Stable Renal Transplantation

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 2897-2899

  Ruiz Fuentes, M C ^a   Moreno Ayuso, J M ^a   Ruiz Fuentes, N ^b   Vargas Palomares, J F ^a   Asensio Peinado, C ^a   Osuna Ortega, A ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CATALASE; CREATININE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACETYLCYSTEINE; CATALASE; CHOLESTEROL; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIPIDS; LIPOPROTEINS, HDL; MALONDIALDEHYDE;

EID: 55749114903     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.109     Document Type: Article

References (12)

1. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154
2. Moreno J.M., Ruiz M.C., Ruiz N., et al. Modulation factors of oxidative status in stable renal transplantation. Transplant Proc 37 (2005) 1428
3. Boratyriska M., Boratyriska J., Klinger M., et al. Lipid peroxidation and cytokines in chronic allograft failure: influence of nonimmunological risk factors. Transplant Proc 32 (2000) 1384
4. Aruoma O.I., Halliwell B., Hoey B.M., et al. The antioxidant action of N-acetylcysteine: its action with hydrogen peroxide, hydroxyl radical, superoxide and hipochlorous acid. Free Radic Biol Med 6 (1989) 593
5. Nitescu N., Ricksten S.E., Marcussen N., et al. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion. Nephrol Dial Transplant 21 (2006) 1240
6. Cristol J.P., Vela C., Maggi M.F., et al. Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation 65 (1998) 1322
7. Trimarchi H., Mongitore M.R., Baglioni P., et al. N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients: a pilot study. Clin Nephrol 59 (2003) 441
8. Tepel M., van der Giet M., Statz M., et al. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 107 (2003) 992
9. Drager L.F., Andrade L., Barros de Toledo J.F., et al. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant 19 (2004) 1803
10. Shimizu M.H., Coimbra T.M., de Araujo M., et al. N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int 68 (2005) 2208
11. Franceschini G., Werba J.P., Safa O., et al. Dose-related increase of HDL-cholesterol levels after N-acetylcysteine in man. Pharmacol Res 28 (1993) 213
12. Kinscherf R., Cafaltzis K., Roder F., et al. Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects. Free Radic Biol Med 35 (2003) 1286